1 / 4

Cancer Biomarkers Market Rapid Extension During 2020-2025

Global Cancer Biomarkers Market is expected to grow at a CAGR of 14.38% during the forecast period 2021 to 2025. The market is segmented into Type (Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, and Others), Cancer Type, Application, Profiling Technology, End Users, and Region. A market report by Foster Market Research provides deep market insight that will help your business to grow with an improved go-to-market business strategy.

6863
Download Presentation

Cancer Biomarkers Market Rapid Extension During 2020-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Biomarkers Market Foreseen To Grow Exponentially Over 2025 The global cancer biomarkers market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of 14.38% during the forecast period (2020−2025). Cancer biomarkers are biomolecules produced either by the tumor cells or by other cells of the body in reaction to the tumor. Biomarkers can be genes, gene products, specific cells, molecules, enzymes, or hormones which can be perceived in blood, urine, tissues, or other body fluid. New product launches for cancer biomarkers is projected to boost growth of the market. For instance, in May 2019, Roche launched a new assay that can detect the Human Epidermal Growth Factor Receptor 2 (HER2) biomarker in breast and gastric cancer in the U.K. HER2 is an important biomarker found in breast and gastric cancers. This assay allows faster cancer detection. Key Insights: Latest Updates Analyst Views Future Outlook of the Market ● ● ● Get Free PDF Brochure of this Report @ https://www.fostermarketresearch.com/product/industry/biotechnology/glo bal-cancer-biomarkers-market/Pdf%20Brochure/ Competitive Landscape: Key players in the global cancer biomarkers market include: Abbott Laboratories Inc., Agilent Technologies, 23andMe, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., bioMérieux, Inc., Creative Diagnostics, Illumina Inc., and Thermo Fisher Scientific among others. Rise in reimbursement programs by government or key players is probable to enhance the market growth. For instance, in July 2018, German Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to evaluate the benefits and potential harm resulting from the use of biomarker-based tests to help doctors decide whether patients with primary breast cancer should receive adjuvant chemotherapy after surgery. Once feedbacks received, company is proposed to provide reimbursements for the biomarker products. Market Taxonomy:

  2. By Type Genetic Biomarkers Protein Biomarkers Epigenetic Biomarkers Metabolic Biomarkers Others ● ● ● ● ● By Cancer Type Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Cervical Cancer Liver Cancer Others ● ● ● ● ● ● ● By Application Prognostics Research and Development Risk Assessment Disease Diagnosis ● ● ● ● By Profiling Technology Immunoassay Imaging Technology Cytogenetics OMICS Technology Others ● ● ● ● ● By End Users Hospitals Academic and Cancer Research Institutes Diagnostic Laboratories Ambulatory Surgical Centers ● ● ● ● By Region North America Europe Asia-Pacific Latin America Middle East and Africa ● ● ● ● ●

  3. Talk To Analyst @ https://www.fostermarketresearch.com/product/industry/biotechnology/glo bal-cancer-biomarkers-market/Talk-to-Analyst/ Market Dynamics: Rise in partnerships among the key players to obtain faster drug results is estimated to lift global cancer biomarkers market over the forecast period. For instance, in November 2018, Biocartis Group signed an agreement with AstraZeneca to receive faster lung cancer molecular diagnostic biomarker results in Europe. Under the agreement, both the companies collaborated to conduct prospective lung cancer study with Biocartis’s Idylla EGFR Mutation Test (CE-IVD) in more than 12 countries in Europe such as in Belgium, France, Germany and Italy. However, product recalls by key players due to failure in working is projected to hinder the growth of global cancer biomarkers market during the forecast period. For instance, in October 2018, Ventana Medical Systems recalled FLO-LOK III Dispenser Detection kits due to leaking and sticking of reagent dispensers which could cause false negative results. FLO-LOK III Dispenser is used to indicate a disease state through the detection of biomarkers. FAQ's: Note: This report provides an in-depth analysis of the global cancer biomarkers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year. What are the trends adopted by key players in the global cancer biomarkers market? What key factors are expected to increase the demand for global cancer biomarkers market during the forecast period 2020-2025? What are the major challenges inhibiting the growth of the global cancer biomarkers market? Which type (genetic biomarkers, protein biomarkers, epigenetic biomarkers, metabolic biomarkers, and others) is expected to dominate the global cancer biomarkers market in the coming years? Which application (prognostics, research and development, risk assessment, and disease diagnosis) is expected to propel the market in the foreseen future? Which profiling technology (immunoassay, imaging technology, cytogenetics, OMICS technology, and others) is expected to propel the market in the forecasted future? What is the total market value (US$ Mn) generated in the global cancer biomarkers market by cancer type in 2019, and what are the forecasts by 2025? ● ● ● ● ● ● ● Buy Now This Business Strategic Report to Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/biotechnology/225/

  4. About Foster Market Research: Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data. Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience. Contact Us: 1701 Royal Lane, #1306, Dallas Tx-75229 Phone: +1 469 4981929 Email: support@fostermarketresearch.com

More Related